Neuroscience Research Australia

Futó vizsgálatok

• Toboroz

  A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

  NCT07369076· 1/2. fázis· Nura Bio· Forrás

• Toboroz

  Steps Against the Burden of Parkinson's Disease

  NCT07057219· The University of New South Wales· Forrás

• Toboroz

  A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  NCT05552157· 2/3. fázis· Washington University School of Medicine· Forrás

• Toboroz

  A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  NCT06647498· 2/3. fázis· Washington University School of Medicine· Forrás

• Fut, nem toboroz

  DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease

  NCT06384573· 3. fázis· Washington University School of Medicine· Forrás

• Toboroz

  The Natural History of Mitochondrial Diseases

  NCT06504433· Neuroscience Research Australia· Forrás

• Toboroz

  Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

  NCT05650229· 2. fázis· Pharming Technologies B.V.· Forrás

• Fut, nem toboroz

  Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)

  NCT05269394· 2/3. fázis· Washington University School of Medicine· Forrás

• Fut, nem toboroz

  An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS

  NCT05299658· 2. fázis· Clene Nanomedicine· Forrás

• Fut, nem toboroz

  Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

  NCT01760005· 2/3. fázis· Washington University School of Medicine· Forrás

• Toboroz

  Dominantly Inherited Alzheimer Network (DIAN)

  NCT00869817· Washington University School of Medicine· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Alzheimer-kór3 toboroz
• Mitochondrial disease2 toboroz
• Amiotrófiás laterálszklerózis (ALS)1 toboroz
• Parkinson-kór1 toboroz

Lezárt vizsgálatok

• Leállították

  An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)

  NCT06961344· 2. fázis· Tisento Therapeutics· Forrás

• Lezárult

  A Phase 2b Study of Zagociguat in Patients With MELAS

  NCT06402123· 2. fázis· Tisento Therapeutics· Forrás

• Lezárult

  Digital Health Technology for People With Mitochondrial Disease

  NCT06535646· Neuroscience Research Australia· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Amiotrófiás laterálszklerózis (ALS)20 munka · 2 vizsgálat
• Bipoláris zavar20 munka · 0 vizsgálat
• Spinal cord injury18 munka · 0 vizsgálat
• Spinális izomatrófia (SMA)6 munka · 0 vizsgálat